Skip to Main Content

Paper Details

BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.
Nat Genet
117
2015
BAZ2A, CpG, EZH2, Prostate cancer, TIP5, cancer, cancer cells, cancers, gene, human, molecular subtype, prostate cancer, protein-coding genes, rRNA
Author NameAffiliation
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Mark D Robinson1] Institute of Molecular Life Sciences, University of Zurich
Holger S??ltmannGerman Cancer Research Center (DKFZ) and National Center of Tumour Diseases
Marie-Laure YaspoMax Planck Institute for Molecular Genetics
Benedikt BrorsGerman Cancer Research Center (DKFZ)
Benedikt BrorsGerman Cancer Research Center (DKFZ)
Jan O Korbel
Jan O Korbel
Thorsten SchlommMartini Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Roland EilsGerman Cancer Research Center (DKFZ), Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University
Roland EilsGerman Cancer Research Center (DKFZ), Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University
Christoph PlassGerman Cancer Research Center (DKFZ)
Raffaella SantoroInstitute of Veterinary Biochemistry and Molecular Biology, University of Zurich
Raffaella SantoroInstitute of Veterinary Biochemistry and Molecular Biology, University of Zurich
  • 1 - 15

Datasets

Release 1.2